184 related articles for article (PubMed ID: 23165953)
21. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
22. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
23. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.
Johnson RH; Chien FL; Bleyer A
JAMA; 2013 Feb; 309(8):800-5. PubMed ID: 23443443
[TBL] [Abstract][Full Text] [Related]
24. Risk-adjusted female breast cancer incidence rates in the United States.
Merrill RM; Sloan A
Cancer Epidemiol; 2012 Apr; 36(2):137-40. PubMed ID: 21903503
[TBL] [Abstract][Full Text] [Related]
25. Young premenopausal women with breast cancer, especially estrogen receptor negative, are at significantly increased risk for subsequent ovarian cancer.
Lehrer S; Rheinstein PH; Green S; Rosenzweig KE
Discov Med; 2016 Oct; 22(121):209-213. PubMed ID: 27875672
[TBL] [Abstract][Full Text] [Related]
26. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
27. Increased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer.
Lopez-Rivera V; Zhu P; Dono A; Lee S; Chen PR; Ballester LY; Sheth SA; Esquenazi Y
World Neurosurg; 2020 Jul; 139():e271-e285. PubMed ID: 32298823
[TBL] [Abstract][Full Text] [Related]
28. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
29. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.
Cortesi L; Turchetti D; Marchi I; Fracca A; Canossi B; Rachele B; Silvia R; Rita PA; Pietro T; Massimo F
BMC Cancer; 2006 Aug; 6():210. PubMed ID: 16916448
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
Domchek SM; Gaudet MM; Stopfer JE; Fleischaut MH; Powers J; Kauff N; Offit K; Nathanson KL; Robson M
Breast Cancer Res Treat; 2010 Jan; 119(2):409-14. PubMed ID: 19885732
[TBL] [Abstract][Full Text] [Related]
32. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
33. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors.
Nasioudis D; Wilson E; Mastroyannis SA; Sisti G; Haggerty AF; Ko EM; Latif NA
Anticancer Res; 2019 Sep; 39(9):4971-4975. PubMed ID: 31519603
[TBL] [Abstract][Full Text] [Related]
34. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
35. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.
Ernster VL; Barclay J; Kerlikowske K; Wilkie H; Ballard-Barbash R
Arch Intern Med; 2000 Apr; 160(7):953-8. PubMed ID: 10761960
[TBL] [Abstract][Full Text] [Related]
36. Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer.
Sokol ES; Feng YX; Jin DX; Basudan A; Lee AV; Atkinson JM; Chen J; Stephens PJ; Frampton GM; Gupta PB; Ross JS; Chung JH; Oesterreich S; Ali SM; Hartmaier RJ
Ann Oncol; 2019 Jan; 30(1):115-123. PubMed ID: 30423024
[TBL] [Abstract][Full Text] [Related]
37. Declining second primary ovarian cancer after first primary breast cancer.
Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
[TBL] [Abstract][Full Text] [Related]
38. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
39. Melanoma in individuals with neurofibromatosis type 1: a retrospective study.
Zhang M; Bhat T; Gutmann DH; Johnson KJ
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045143
[TBL] [Abstract][Full Text] [Related]
40. A cohort study of reproductive factors and family history of breast cancer in southern Sweden.
Olsson H; Bladström A
Breast Cancer Res Treat; 2002 Dec; 76(3):203-9. PubMed ID: 12462381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
